BMC Gastroenterology

official impact factor 2.47
Search for
Advanced search
BMC Gastroenterology
Tools
Share this article
Open Access Highly Access Email this article to a friend

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo*, Nuria Fernández, Francisca L Sousa, Encarnación Cabrera, Manuel Castro, Luz M Ramírez, Robin Rivera, Esther Ubiña, Francisco Vera, Isabel Méndez, Francisco Rivas-Ruiz, José L Moreno and Emilio Perea-Milla

BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.